Horizon Therapeutics Public Limited Company
Hedge Funds Holdings
Last updated:
Horizon Therapeutics Public Limited Company‘s stocks are currently a part of 589 hedge funds’ portfolios, which represents 85.87% of the total amount of its stocks outstanding. This makes up a total of 202.60M shares of Horizon Therapeutics Public Limited Company. Compared to the previous quarter, the number fell by -0.73% or -1.48M shares fewer. As for the holding position changes, 40.92% (241) of current hedge fund investors increased the number of shares held, 34.13% (201) of current holders sold a part of the shares held, and 13.41% (79) closed the holdings completely. 74 hedge funds are new holders of Horizon Therapeutics Public Limited Company stock in Q2 2022, it is 12.56% of total holders.
Hedge funds holding Horizon Therapeutics Public Limited Company (Q3 2017 – Q2 2022)
Q3 2017 | 180 |
---|---|
Q4 2017 | 183 |
Q1 2018 | 202 |
Q2 2018 | 205 |
Q3 2018 | 219 |
Q4 2018 | 236 |
Q1 2019 | 295 |
Q2 2019 | 262 |
Q3 2019 | 259 |
Q4 2019 | 274 |
Q1 2020 | 289 |
Q2 2020 | 345 |
Q3 2020 | 420 |
Q4 2020 | 480 |
Q1 2021 | 499 |
Q2 2021 | 513 |
Q3 2021 | 551 |
Q4 2021 | 589 |
Q1 2022 | 601 |
Q2 2022 | 589 |
Hedge funds changes in Horizon Therapeutics Public Limited Company positions (Q3 2017 – Q2 2022)
Q3 2017 | 28 | 65 | 59 | 38 | -10 |
---|---|---|---|---|---|
Q4 2017 | 37 | 62 | 61 | 32 | -9 |
Q1 2018 | 38 | 65 | 65 | 17 | 17 |
Q2 2018 | 41 | 69 | 61 | 36 | -2 |
Q3 2018 | 44 | 64 | 87 | 30 | -6 |
Q4 2018 | 50 | 82 | 76 | 34 | -6 |
Q1 2019 | 92 | 102 | 78 | 33 | -10 |
Q2 2019 | 240 | 10 | 8 | 268 | -264 |
Q3 2019 | 52 | 74 | 105 | 55 | -27 |
Q4 2019 | 50 | 85 | 102 | 27 | 10 |
Q1 2020 | 56 | 96 | 109 | 39 | -11 |
Q2 2020 | 95 | 95 | 130 | 38 | -13 |
Q3 2020 | 114 | 148 | 139 | 37 | -18 |
Q4 2020 | 126 | 168 | 156 | 65 | -35 |
Q1 2021 | 92 | 181 | 182 | 66 | -22 |
Q2 2021 | 71 | 213 | 157 | 53 | 19 |
Q3 2021 | 80 | 213 | 186 | 41 | 31 |
Q4 2021 | 92 | 223 | 207 | 46 | 21 |
Q1 2022 | 87 | 247 | 205 | 68 | -6 |
Q2 2022 | 74 | 241 | 201 | 79 | -6 |
Hedge funds changes in Horizon Therapeutics Public Limited Company stock options (Q3 2017 – Q2 2022)
Q3 2017 | 35,496,000 | 13,233,000 |
---|---|---|
Q4 2017 | 30,457,000 | 26,963,000 |
Q1 2018 | 18,743,000 | 8,819,000 |
Q2 2018 | 16,363,000 | 7,556,000 |
Q3 2018 | 22,783,000 | 7,666,000 |
Q4 2018 | 19,459,000 | 9,206,000 |
Q1 2019 | 43,793,000 | 25,098,000 |
Q2 2019 | 11,624,000 | 15,574,000 |
Q3 2019 | 17,292,000 | 8,317,000 |
Q4 2019 | 33,405,000 | 24,136,000 |
Q1 2020 | 15,287,000 | 11,705,000 |
Q2 2020 | 63,077,000 | 21,683,000 |
Q3 2020 | 115,878,000 | 144,150,000 |
Q4 2020 | 38,000,280,421,000 | 112,223,000 |
Q1 2021 | 207,489,000 | 167,467,000 |
Q2 2021 | 162,132,000 | 77,902,000 |
Q3 2021 | 388,810,000 | 102,442,000 |
Q4 2021 | 115,142,688 | 86,340,000 |
Q1 2022 | 156,301,000 | 77,998,000 |
Q2 2022 | 84,442,000 | 35,460,000 |